Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trialNicola G. Ghazi, Fowzan S. Alkuraya, Emad B. Abboud et al.|Human Genetics|2016Cited by 242
The Human Rhodopsin Kinase Promoter in an AAV5 Vector Confers Rod- and Cone-Specific Expression in the Primate RetinaSanford L. Boye, Paul D. Gamlin, John Alexander et al.|Human Gene Therapy|2012Cited by 111
Preclinical Potency and Safety Studies of an AAV2-Mediated Gene Therapy Vector for the Treatment of <i>MERTK</i> Associated Retinitis PigmentosaThomas J. Conlon, William W. Hauswirth, Wen‐Tao Deng et al.|Human Gene Therapy Clinical Development|2013Cited by 95
LHON Gene Therapy Vector Prevents Visual Loss and Optic Neuropathy Induced by G11778A Mutant Mitochondrial DNA: Biodistribution and Toxicology ProfileRajeshwari D. Koilkonda, Josephine M. Guy, William J. Feuer et al.|Investigative Ophthalmology & Visual Science|2014Cited by 67
Long-term Preservation of Cone Photoreceptors and Restoration of Cone Function by Gene Therapy in the Guanylate Cyclase-1 Knockout (GC1KO) MouseSanford L. Boye, Thomas J. Conlon, Kirsten Erger et al.|Investigative Ophthalmology & Visual Science|2011Cited by 63